Co-Diagnostics files S-3 for 3,404,724 secondary shares
Co-Diagnostics files a Form S-3 covering 3,404,724 shares of common stock offered by selling stockholders.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.